Literature DB >> 20851131

Atorvastatin treatment affects atrial ion currents and their tachycardia-induced remodeling in rabbits.

Roman Laszlo1, Karen Anna Menzel, Kerstin Bentz, Birgit Schreiner, Klaus Kettering, Christian Eick, Juergen Schreieck.   

Abstract

AIMS: Atrial fibrillation (AF) leads to electrical atrial remodeling including alterations of various ion channels early after arrhythmia onset. The beneficial effects of statins in AF treatment due to their influence on oxidative stress and inflammation are discussed. Our hypothesis was that statins might also alter atrial ion currents and their early tachycardia-induced remodeling. MAIN
METHODS: Effects of an atorvastatin treatment (7 days) on atrial ion currents and their tachycardia-induced alterations were studied in a rabbit model of tachycardia-induced electrical remodeling (rapid atrial pacing (600 min) for 24 and 120 h). Ion currents (L-type calcium channel [I(Ca,L)], transient outward current [I(to)]) were measured using whole cell patch clamp method and were compared with previous experiments in untreated but also tachypaced animals. KEY
FINDINGS: Atorvastatin treatment alone decreased I(Ca,L) similar to rapid atrial pacing alone, currents were also further reduced by additional atrial tachypacing. I(to) and its pacing-induced down-regulation after 24 h were not influenced by atorvastatin treatment. However, I(to) was still reduced after 120 h in atorvastatin-treated animals and did not return to control values as expected. SIGNIFICANCE: The present study establishes that an atorvastatin treatment can affect atrial ion currents and their tachycardia-induced remodeling in a rabbit model. These results show that-amongst other positive effects on oxidative stress and inflammation-the impact of statins on ion currents and their tachycardia-induced alterations might also play a role in "upstream" treatment of AF with HMG-CoA reductase inhibitors.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20851131     DOI: 10.1016/j.lfs.2010.09.010

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Protective role of simvastatin on isolated rabbit atrioventricular node during experimental atrial fibrillation model: role in rate control of ventricular beats.

Authors:  Vahid Khori; Soroosh Aminolsharieh Najafi; Ali Mohammad Alizadeh; Hamid Reza Moheimani; Delaram Shakiba; Fatemeh Alizadeh; Mohsen Nayebpour
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-04-28       Impact factor: 3.000

2.  Atorvastatin blocks increased l-type Ca2+ current and cell injury elicited by angiotensin II via inhibiting oxide stress.

Authors:  Yanzhuo Ma; Lingfeng Kong; Shuying Qi; Dongmei Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-03-02       Impact factor: 3.848

3.  Attenuation of acetylcholine activated potassium current (I KACh) by simvastatin, not pravastatin in mouse atrial cardiomyocyte: possible atrial fibrillation preventing effects of statin.

Authors:  Kyoung-Im Cho; Tae-Joon Cha; Su-Jin Lee; In-Kyeung Shim; Yin Hua Zhang; Jung-Ho Heo; Hyun-Su Kim; Sung Joon Kim; Kyoung-Lyoung Kim; Jae-Woo Lee
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

Review 4.  Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.

Authors:  Alexios S Antonopoulos; Marios Margaritis; Regent Lee; Keith Channon; Charalambos Antoniades
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 5.  Anti-arrhythmic properties of non-antiarrhythmic medications.

Authors:  Emmanuel Ato Williams; Vincenzo Russo; Sergio Ceraso; Dhiraj Gupta; Richard Barrett-Jolley
Journal:  Pharmacol Res       Date:  2020-03-23       Impact factor: 7.658

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.